Skip to main content

‘Activist’ shareholder demands change at Elementis

1st May 2024

Submitted by:

Andrew Warmington

Gatemore Capital Management has published an open letter to John O’Higgins, chairman of the board at UK-based speciality chemicals company Elementis, stating that there is “an urgent need for change”. This echoes a letter from another ‘activist’ shareholder in late 2023.

Elementis mainly supplies the personal care sector, notably cosmetic and antiperspirant actives – it is the world market leader in the latter field. 85% of its products are of natural origin. Coatings and paper are other key markets.

Gatemore, which has a 0.6% stake, said that there is a between the firm’s “fundamental strength” and its “persistently weak share price. Having already engaged to this effect, it said that is going public about how Elementis should act “to rebuild investor confidence and unlock significant value for its shareholders”.

According to Gatemore, Elementis “is an attractive business that has lost its direction” and should be doing better, based on various factors:  the importance of rheology modifiers in product formulation; customer loyalty, especially in coatings; owning a hectorite mine in California, which is a key competitive advantage; expertise in rheology modifiers with market-leading R&D capabilities; and consistently strong historical gross profit margins.

Nonetheless, its performance has been very weak and this, Gatemore said, is largely self-inflicted. This it blamed above all on CEO Paul Waterman. Since he took over in 2016, Elementis has total shareholder returns 86% lower than its peers and 76% lower than the FTSE 250, despite three takeover approaches boosting the share price.

In particular, Gatemore cited: poor capital allocation with a $650 million net spend on M&A, over a half of its current entire market capitalisation, most obviously overspending on Mondo Minerals; repeated operational underperformance; and rejecting three takeover approaches from Minerals Technologies and Innospec in 2020-1.

In addition, Gartmore said, “Elementis’ self-help measures are woefully inadequate”. The $20 million ‘Fit for Future’ cost-saving programme announced at a Capital Markets Day in November 2023 could and should have been implemented earlier, while analysts remain sceptical abut the management’s ability to deliver its EBIT targets. Gatemore concluded by asking the company to:

* Accelerate and confirm the details around the programme

* Replace Waterman and appoint new non-executive director Heejae Chae to lead the search process

* Conduct a strategic review of the portfolio with the aim of refocusing and making it more attractive for a strategic buyer

Gatemore added that it had spoken to other shareholders and believed that most were in agreement. Furthermore, it claimed to have “a strong track record of unlocking value in UK small- and mid-caps for all shareholders”, citing DX Group as an example.

Elementis did not directly respond. Instead, it said: ‘The board continues to believe that shareholder value is best driven by a focus on delivering the substantial actions that are currently being progressed at pace throughout the business and that underpin progress towards the 2026 targets of 19%+ operating margin, over 90% cash conversion and over 20% return on capital, generated by $90 million of above market revenue growth and $30 million cost savings.”

In November 2023, another activist, Franklin Mutual Advisers, had published a similar open letter O’Higgins, calling for Elementis to put itself up for sale. It accused the company of “a shocking amount of shareholder value destruction”, mainly from buying SummitReheis and Mondo Minerals. Elementis declined, saying it did not think this to be in shareholders’ best interests.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington